https://www.selleckchem.com/pr....oducts/nf-kb-activat
45; p=0.003). Baseline and follow-up radiographs were available for 54 patients; 17/54 (31.5%) patients experienced radiographic damage progression. BMO (HR=4.40; p=0.045) and age 17 years (HR= 3.51; p=0.04) were strong predictors of joint damage progression in the multivariable analysis. MRI-detected subclinical inflammation was present in a large proportion of patients with JIA despite clinical remission. Subclinical synovitis and BMO have been shown to play a role in predicting the risk of disease relapse and joint det
Like
Comment
Share
